Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation

Area of Science:

• Cardiology
• Interventional Cardiology
• Cardiac Surgery

Background:

• Transcatheter aortic valve replacement (TAVR) is standard for severe aortic stenosis in high-risk patients.
• Native aortic valve regurgitation (AVR) is a relative contraindication for TAVR due to anchoring challenges.
• Aortic root or ascending aorta dilatation often accompanies severe AVR, complicating TAVR.

Purpose of the Study:

• To review the clinical context of transcatheter treatment for native aortic valve regurgitation.
• To discuss the technical aspects of using newer-generation valves and devices for pure aortic incompetence.
• To evaluate the outcomes of transcatheter aortic valve replacement in patients with native aortic regurgitation.

Main Methods:

• Review of clinical data and outcomes for transcatheter aortic valve replacement in native aortic regurgitation.
• Analysis of newer-generation transcatheter heart valves and ancillary devices for annulus-root stabilization.
• Examination of patient selection and procedural considerations for TAVR in pure aortic incompetence.

Main Results:

• Transcatheter aortic valve replacement for native AVR has been sporadically used, primarily in inoperable patients.
• Emerging data with newer valves and devices show encouraging results for TAVR in native AVR.
• Ancillary devices are being developed to improve secure anchoring in the annulus-root complex.

Conclusions:

• Transcatheter aortic valve replacement is increasingly being explored for native aortic regurgitation.
• Newer TAVR technologies and devices may expand treatment options for pure aortic incompetence.
• Careful patient selection and procedural techniques are crucial for successful TAVR in native AVR.